Patrick J. Mahaffy Net Worth

The estimated Net Worth of Patrick J Mahaffy is at least $1.24 Million dollars as of 29 August 2019. Mr Mahaffy owns over 30,824 units of Clovis Oncology Inc stock worth over $2,466 and over the last 13 years he sold CLVS stock worth over $0. In addition, he makes $1,234,574 as Co-Founder, CEO, and Pres & Exec. Director at Clovis Oncology Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Mahaffy CLVS stock SEC Form 4 insiders trading

Mr has made over 3 trades of the Clovis Oncology Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 30,824 units of CLVS stock worth $4,932 on 29 August 2019.

The largest trade he's ever made was buying 50,000 units of Clovis Oncology Inc stock on 16 August 2019 worth over $279,500. On average, Mr trades about 4,472 units every 105 days since 2011. As of 29 August 2019 he still owns at least 30,824 units of Clovis Oncology Inc stock.

You can see the complete history of Mr Mahaffy stock trades at the bottom of the page.

Mr. Patrick J. Mahaffy biography

Patrick J. Mahaffy is the Co-Founder, CEO, Pres & Exec. Director at Clovis Oncology Inc.

What is the salary of Mr Mahaffy?

As the Co-Founder, CEO, and Pres & Exec. Director of Clovis Oncology Inc, the total compensation of Mr Mahaffy at Clovis Oncology Inc is $1,234,574. There are no executives at Clovis Oncology Inc getting paid more.

How old is Mr Mahaffy?

Mr Mahaffy is 58, he's been the Co-Founder, CEO, and Pres & Exec. Director of Clovis Oncology Inc since . There are 2 older and 4 younger executives at Clovis Oncology Inc. The oldest executive at Clovis Oncology Inc is Dr. Gillian C. Ivers-Read BSc, 67, who is the Co-Founder, Exec. VP & Chief Regulatory Officer.

What's Mr Mahaffy's mailing address?

Patrick's mailing address filed with the SEC is C/O CLOVIS ONCOLOGY, INC., 5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO, 80301.

Insiders trading at Clovis Oncology Inc

Over the last 13 years, insiders at Clovis Oncology Inc have traded over $37,405,827 worth of Clovis Oncology Inc stock and bought 24,337,722 units worth $298,497,645 . The most active insiders traders include Forest Baskett, Scott D Sandell, and Peter J Barris. On average, Clovis Oncology Inc executives and independent directors trade stock every 17 days with the average trade being worth of $8,863. The most recent stock trade was executed by Paul Edward Gross on 1 November 2022, trading 10,248 units of CLVS stock currently worth $820.

What does Clovis Oncology Inc do?

Complete history of Mr Mahaffy stock trades at Clovis Oncology Inc and Flexion Therapeutics Inc

Clovis Oncology Inc executives and stock owners

Clovis Oncology Inc executives and other stock owners filed with the SEC include:

• Patrick J. Mahaffy,
  Co-Founder, CEO, Pres & Exec. Director
• Dr. Lindsey Rolfe B.Sc., BSc, MB ChB, MRCP, FFPM,
  Exec. VP of Clinical Devel. & Pharmacovigilance and Chief Medical Officer
• Patrick J. Mahaffy MA,
  Co-Founder, CEO, Pres & Exec. Director
• Dr. Gillian C. Ivers-Read,
  Co-Founder, Chief Regulatory Officer & Exec. VP of Technical Operations
• Paul Edward Gross,
  Exec. VP, Gen. Counsel & Sec.
• Daniel W. Muehl,
  Exec. VP & CFO
• Dr. Gillian C. Ivers-Read BSc,
  Co-Founder, Exec. VP & Chief Regulatory Officer
• Anna Sussman,
  VP of Investor Relations
• Ann Bozeman,
  Exec. VP of HR
• Breanna Burkart,
  VP of Investor Relations & Corp. Communications
• Dr. Thomas Fuglsang Harding B.Sc., Ph.D.,
  Exec. VP & Chief Scientific Officer
• Keith T. Flaherty,
  Director
• Daniel W Muehl,
  See Remarks
• Lindsey Rolfe,
  See Remarks
• Thorlef Spickschen,
  Director
• Paul H Klingenstein,
  Director
• M James Barrett,
  Director
• Gillian C Ivers Read,
  See Remarks
• Ginger L Graham,
  Director
• Corwin Dale Hooks,
  See Remarks
• Edward J Mc Kinley,
  Director
• Brian G Atwood,
  Director
• Patrick J Mahaffy,
  See Remarks
• Richard A. Fair,
  Director
• Robert Azelby,
  Director
• Paul Edward Gross,
  See Remarks
• Erle T Mast,
  Executive VP and CFO
• Enterprise Associates 13 Lp...,
  
• Harry R Weller,
  10% owner
• John C Reed,
  Director
• Patrick J Kerins,
  10% owner
• Kathleen K Schoemaker,
  10% owner
• C Richard Kramlich,
  10% owner
• Parters Vii L Pblair James ...,
  
• Peter J Barris,
  10% owner
• Brian H Dovey,
  10% owner
• Steven L. Hoerter,
  SEE REMARKS
• Jesse I Treu,
  10% owner
• Ravi Viswanathan,
  10% owner
• Partners 13, Limited Partne...,
  
• Vii Associates Lp Dp,
  10% owner
• Venture Capital Iv, L.P.Ver...,
  
• David M Mott,
  10% owner
• Scott D Sandell,
  10% owner
• Brian K Halak,
  10% owner
• Nicole Vitullo,
  10% owner
• Vii Associates Lpblair Jame...,
  
• Krishna Kittu Kolluri,
  10% owner
• Ryan D Drant,
  10% owner
• Parters Vii L P Domain,
  10% owner
• Forest Baskett,
  10% owner
• Enterprise Associates 13 Lp...,
  10% owner
• James C Blair,
  Director
• Thomas C. Harding,
  See Remarks